Rubicon Organics Reports Q3 2025 Financial and Operating Results

Core Insights - Rubicon Organics Inc. reported strong financial results for Q3 2025, with net revenue of CAD 15.6 million, a 16% increase year-over-year, and Adjusted EBITDA of CAD 1.7 million, reflecting operational scale and cost control [3][8][9] Financial Performance - Q3 2025 net revenue reached CAD 15.6 million, up from CAD 13.5 million in Q3 2024, while year-to-date (YTD) revenue for 2025 was CAD 43.0 million, a 25% increase compared to the same period in 2024 [9][12] - Adjusted EBITDA for Q3 2025 was CAD 1.7 million, with YTD Adjusted EBITDA at CAD 3.8 million, marking the sixth consecutive quarter of positive Adjusted EBITDA [3][9][12] - Gross profit for Q3 2025 was CAD 8.0 million, with a gross profit margin of 33.7%, compared to 32.4% in Q3 2024 [12] Market Position and Growth Strategy - The company has a national market share of 6.2% in premium flower and pre-rolls, 13.2% in premium vapes, and 16.0% in premium edibles for Q3 2025 [9] - Rubicon's acquisition of the Cascadia Facility is expected to increase production capacity by over 40%, supporting future growth in both domestic and international markets [7][11] - The company has successfully shipped to three international markets in the fiscal year, indicating a strategic focus on global expansion [9] Operational Highlights - The company has begun investing in talent and foundational initiatives to support growth as it prepares to realize revenue from the Cascadia Facility in 2026 [2][3] - Cash flow from operations for Q3 2025 was CAD 0.5 million, with total current assets amounting to CAD 35.6 million as of September 30, 2025 [9][12] Future Outlook - For fiscal 2025, the company forecasts growth in both net revenue and Adjusted EBITDA, despite anticipated one-time costs related to the Cascadia Facility [11][20] - The company remains confident in its long-term value creation potential, driven by ongoing expansion and strategic initiatives [11][20]